93 7702 (Glimepiride and Rosiglitazone Maleate 4 mg / 8 mg)
Pill with imprint 93 7702 is Red, Round and has been identified as Glimepiride and Rosiglitazone Maleate 4 mg / 8 mg. It is supplied by Teva Pharmaceuticals USA, Inc..
Glimepiride/rosiglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glimepiride/rosiglitazone 4 mg / 8 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 7702
More about glimepiride / rosiglitazone
- Side Effects
- During Pregnancy
- Dosage Information
- Imprints, Shape & Color Data
- Drug Interactions
- 1 Review
- Drug class: antidiabetic combinations
- FDA Alerts (6)
- Other brands
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.